Zurowska, Aleksandra http://orcid.org/0000-0002-3354-5344
Drozynska-Duklas, Magdalena http://orcid.org/0000-0002-1792-1776
Topaloglu, Rezan http://orcid.org/0000-0002-6423-0927
Bouts, Antonia http://orcid.org/0000-0002-4121-6698
Boyer, Olivia http://orcid.org/0000-0002-3957-1359
Shenoy, Mohan http://orcid.org/0000-0002-2456-3006
Vivarelli, Marina http://orcid.org/0000-0002-2448-1959
,
Alpay, H.
Andersen, R.
Ariceta, G.
Atmış, B.
Bayrakçı, U. S.
Esrea, B.
Baudouin, V.
Bervina, N.
Benetti, E.
Berard, E.
Bjerre, A.
Christian, M.
Couderc, A.
Dehoorne, J.
Deschenes, G.
Dossier, C.
Düşünsel, R.
Ekinci, Z.
Emma, F.
Espinoza, L.
Gianviti, A.
Herrero Goñi, M.
Guido, G.
Ghio, L.
Groothoff, J.
Hacıhamdioğlu, D. Ö.
Espino Hernández, M.
Jankauskiene, A.
Kagan, M.
Kemper, M.
Kovacevic, M.
Kohl, S.
Kramar, R. T.
López-González, M.
Aris, A. M.
Maringhini, S.
Marlais, M.
Melgosa, M.
Mitsioni, A.
Montini, G.
Moczulska, A.
Murer, L.
Obukhova, V.
Oh, J.
Ortega, P.
Özçakar, Z. B.
Ulinski, T.
Pasini, A.
Papalia, T.
Paunova, S.
Pena, A.
Pecoraro, C.
Petrosyan, E.
Peruzzi, L.
Printza, N.
Prikhodina, L.
Pietrement, C.
Rittig, S.
Rodrigo, D.
Savenkova, N.
Saraga, M.
Sever, F. L.
Schreuder, M.
Szczepanska, M.
Tasic, V.
Tonshoff, B.
Tullus, K.
Vara, J.
Vande Walle, J.
Volokhina, E.
Zieg, J.
Waters, A.
Weber, L. T.
Webbe, N.
Wasiak, M.
Endén, K.
Tsygin, A.
Grenda, R.
Raes, A.
Van Hoeck Koen, J. M.
Adams, B.
Aksenova, M.
Ranchin, B.
Hooman, N.
Ogarek, I.
Seeman, T.
Fila, M.
Oni, L.
Mir, S.
Novo, R.
Stabouli, S.
Vara-Martín, J.
van Wijk, J. A. E.
Ehren, R.
Bekassy, Z.
Herthelius, M.
Becherucci, F.
Shasha-Lavsky, H.
Santos, F.
Feldkötter, M.
Pańczyk-Tomaszewska, M.
Harambat, J.
Grima, D.
Gökçe, I.
Teixeira, A.
Licht, C.
Schmidt, I. M.
Brandström, P.
Dinçel, N.
Article History
Received: 5 October 2022
Revised: 13 January 2023
Accepted: 8 February 2023
First Online: 4 April 2023
Declarations
:
: 1. Marina Vivarelli declared potential conflict of interests:- Grants – Alexion- Sponsored clinical trials – Chinook, Novartis, Bayer, Rche, Apellis, Travere, Alexion, Chemocentrix- Lectures – Travere, Alexion, WebMD- Consultancy fees – Novartis, Biocryst, Roche- Advisory board – Novartis2. Aleksandra Zurowska declared potential conflict of interests: lectures for Swixx BioPharma3. Mohan Shenoy declared potential conflict of interests: advisory board – Novartis4. Olivia Boyer declared potential conflict of interests: consultancy fees – Rocher5. Magdalena Drozynska-Duklas – no conflict of interests to disclose